Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1Surgical Wound Infection 1Skin Neoplasms 1Neoplasms 1Leukemia, Myeloid, Acute 1Inflammation 1Infections 1Genetic Predisposition to Disease 1Breast Neoplasms 1

Interventions

Negative-Pressure Wound Therapy 5Metronidazole 4Anti-Bacterial Agents 4chlorhexidine gluconate 2Polyethylene Glycols 2Ornidazole 2Neomycin 2Gentamicins 2Erythromycin 2polyethylene glycol 400 1Trimethoprim, Sulfamethoxazole Drug Combination 1Surgical Tape 1Sodium Chloride 1Saline Solution 1Oxygen 1Ointments 1Mupirocin 1Laparoscopy 1Glycols 1Ethanol 1Docosahexaenoic Acids 1Clindamycin 1Cephalexin 1Cefuroxime 1Cefoperazone 1Cefazolin 1Cathartics 1Benchmarking 1Bacitracin 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Surgical Wound Infection × Cephalexin × Clear all
NCT01899690 2017-02-24

Antibiotics and Tissue Expanders in Breast Reconstruction

Emory University

Phase 4 Withdrawn

Infections, Inflammation, Neoplasms, Surgical Wound Infection

Data powered by HemOnc (CC BY 4.0) Colophon âš¡